Climb Bio (CLYM) Non-Current Deferred Tax Liability (2021 - 2025)
Climb Bio (CLYM) posted Non-Current Deferred Tax Liability of $91000.0 for Q4 2025, down 34.06% on a QoQ basis from $138000.0 in Q4 2024, and down 34.06% year-over-year from $138000.0 in Q4 2024.
Climb Bio (CLYM) Non-Current Deferred Tax Liability (2021 - 2025) Analysis & Trends
Climb Bio's Non-Current Deferred Tax Liability history runs 3 years deep, the most recent figure standing at $91000.0 for Q4 2025.
- Quarterly Non-Current Deferred Tax Liability fell 34.06% year-over-year to $91000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $91000.0 (down 34.06% YoY) and the FY2025 annual result came in at $91000.0, down 34.06% from the prior year.
- Non-Current Deferred Tax Liability was $91000.0 for Q4 2025 at Climb Bio, down from $138000.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $138000.0 in Q4 2024 and bottomed at -$11000.0 in Q4 2021.
- A 3-year average of $72666.7 and a median of $91000.0 in 2025 frame the typical range for Non-Current Deferred Tax Liability.
- Peak annual rise in Non-Current Deferred Tax Liability reached 34.06% in 2025, while the deepest fall reached 34.06% in 2025.
- Climb Bio's Non-Current Deferred Tax Liability stood at -$11000.0 in 2021, then soared by 1354.55% to $138000.0 in 2024, then sank by 34.06% to $91000.0 in 2025.
- Business Quant data shows CLYM's Non-Current Deferred Tax Liability at $91000.0 in Q4 2025, $138000.0 in Q4 2024, and -$11000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Climb Bio | 870.33 Mn | 870.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 91,000.00 |
| Dec 31, 2025 | 91,000.00 |
| Dec 31, 2024 | 138,000.00 |
| Dec 31, 2024 | 138,000.00 |
| Dec 31, 2021 | -11,000.00 |
| Dec 31, 2021 | -11,000.00 |